Has Igor Palacios, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,467 in general payments to Igor Palacios, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Igor Palacios, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Igor Palacios, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Igor Palacios, MD

Interventional Cardiology · Boston, MANPI 1376533562

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (33.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Organon accounts for 60.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $2,692 and has fallen 85.5% since, to $390 in 2025.

$7,467in general payments, 2019–2025

Across 39 payments — averaging $191.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organon$5K
Boston Scientific$1K
Abbott$641
Medtronic$375
Edwards Lifesciences$136
Cook Medical LLC$134
plus $235 from 3 others

$152,741in research payments, 2019–2025

Across 26 payments — averaging $5874.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$153K

What the payments were for

Consulting fees$2,00027%
Speaking & faculty fees$2,50033%
Travel & lodging$5928%
Food & beverage$2,37632%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organon	2	$4,500
Boston Scientific	21	$1,445
Abbott	6	$641
Medtronic(2 entities)	4	$375
Edwards Lifesciences	1	$136
Cook Medical LLC	2	$134
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$98
AstraZeneca	1	$79
W. L. Gore & Associates, Inc.	1	$58

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,467 in reported general payments places this provider in the 60th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$27,585

Medicare patients

Services billed

219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$32,977
Metoprolol Succinate	96	$1,705
Valsartan	14	$638
Isosorbide Mononitrate ErIsosorbide Mononitrate	21	$453
Atorvastatin Calcium	42	$393
Losartan Potassium	29	$384
Furosemide	37	$343
Ezetimibe	11	$314
Omeprazole	16	$291
Amlodipine Besylate	42	$222
Lisinopril	21	$125
Enalapril Maleate	13	$114
Simvastatin	12	$73
ClopidogrelClopidogrel Bisulfate	11	$71

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Boston

Eric SecemskyBoston$1.2M
Darshan DoshiBoston$730K
Charles GibsonBoston$661K
Duane PintoBoston$491K
Robert YehBoston$412K
Suzanne BaronBoston$274K
Farouc JafferBoston$213K
Joseph GarasicBoston$152K
Pinak ShahBoston$147K
Douglas DrachmanBoston$132K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →